116 related articles for article (PubMed ID: 22771328)
1. Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells.
Tsukahara T; Haniu H
Biochem Biophys Res Commun; 2012 Aug; 424(3):524-9. PubMed ID: 22771328
[TBL] [Abstract][Full Text] [Related]
2. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
3. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
Au-Yeung KK; Liu PL; Chan C; Wu WY; Lee SS; Ko JK
Cancer Invest; 2008 Aug; 26(7):708-17. PubMed ID: 18608213
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone and 9cis,11trans,13trans-conjugated linolenic acid: comparison of their antiproliferative and apoptosis-inducing effects on different colon cancer cell lines.
Yasui Y; Hosokawa M; Kohno H; Tanaka T; Miyashita K
Chemotherapy; 2006; 52(5):220-5. PubMed ID: 16899971
[TBL] [Abstract][Full Text] [Related]
6. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
[TBL] [Abstract][Full Text] [Related]
7. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
[TBL] [Abstract][Full Text] [Related]
8. Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ.
Tsukahara T; Hanazawa S; Kobayashi T; Iwamoto Y; Murakami-Murofushi K
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):126-33. PubMed ID: 20932931
[TBL] [Abstract][Full Text] [Related]
9. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
Chen A; Xu J
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
[TBL] [Abstract][Full Text] [Related]
11. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
Chintharlapalli S; Papineni S; Baek SJ; Liu S; Safe S
Mol Pharmacol; 2005 Dec; 68(6):1782-92. PubMed ID: 16155208
[TBL] [Abstract][Full Text] [Related]
12. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S
Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
[TBL] [Abstract][Full Text] [Related]
14. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).
Tan BS; Kang O; Mai CW; Tiong KH; Khoo AS; Pichika MR; Bradshaw TD; Leong CO
Cancer Lett; 2013 Aug; 336(1):127-39. PubMed ID: 23612072
[TBL] [Abstract][Full Text] [Related]
15. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
[TBL] [Abstract][Full Text] [Related]
16. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
Kato M; Kusumi T; Tsuchida S; Tanaka M; Sasaki M; Kudo H
J Cancer Res Clin Oncol; 2004 Feb; 130(2):73-9. PubMed ID: 14634802
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
18. Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
Ulrich S; Wächtershäuser A; Loitsch S; von Knethen A; Brüne B; Stein J
Exp Cell Res; 2005 Oct; 310(1):196-204. PubMed ID: 16112107
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
[TBL] [Abstract][Full Text] [Related]
20. Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells.
Ignatenko NA; Babbar N; Mehta D; Casero RA; Gerner EW
Mol Carcinog; 2004 Feb; 39(2):91-102. PubMed ID: 14750214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
